Evidence map›Paper›PMID 30324087›Full record

ArticleWorld journal of nephrology2018

Bicarbonate levels in hemodialysis patients switching from lanthanum carbonate to sucroferric oxyhydroxide.

Aristeidis Stavroulopoulos, Vasiliki Aresti, Christoforos Papadopoulos, Panagiotis Nennes, Polixeni Metaxaki, Anastasios Galinas

Abstract read
In one paragraph

Article in World journal of nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aristeidis StavroulopoulosDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece. stavoulopoulos@yahoo.co.uk.
Vasiliki ArestiDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece.
Christoforos PapadopoulosDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece.
Panagiotis NennesDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece.
Polixeni MetaxakiDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece.
Anastasios GalinasDepartment of Nephrology, IASIO Hospital, General Clinic of Kallithea, Athens 17676, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo examine possible alterations in acid-base parameters in patients switching from lanthanum carbonate (LanC) to sucroferric oxyhydroxide (SFOH).

methodsFifteen stable hemodialysis patients were switched from LanC to SFOH. Only nine continued on SFOH, three returned to LanC and the other three switched to sevelamer carbonate. The later six patients served as a control group to the SFOH group of nine patients. Blood was sampled on the 3-d and the last 2-d interval of the week prior to switching and six weeks after. Bicarbonate levels (HCO

resultsComparing pre-switching to post-switching measurements in the SFOH group, no statistically significant differences were found in any of the parameters studied. The mean pre-switching HCO

conclusionIn our small study, switching from LanC to SFOH did not have any significant effect on blood bicarbonate levels and gas analysis, indicating that there is no need to change hemodialysis prescription regarding these parameters.

Indexed as

AcidosisBicarbonateGas analysisHemodialysisLanthanum carbonatePhosphate binderSucroferric oxyhydroxide

Identifiers

PMID30324087
PMCPMC6181871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.